Letters to the Editor

Melphalan dose intensity for autologous stem cell transplantation in multiple myeloma

Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston
Haematologica Early view Aug 19, 2021 https://doi.org/10.3324/haematol.2021.279179
Multiple myeloma Autologous stem cell transplantation